BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 20097142)

  • 21. Primary sclerosing cholangitis and cholangiocarcinoma.
    Lazaridis KN; Gores GJ
    Semin Liver Dis; 2006 Feb; 26(1):42-51. PubMed ID: 16496232
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Jesudian AB; Jacobson IM
    Rev Gastroenterol Disord; 2009; 9(2):E41-7. PubMed ID: 19668124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distal biliary malignancy.
    Veillette G; Castillo CF
    Surg Clin North Am; 2008 Dec; 88(6):1429-47, xi. PubMed ID: 18992603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The multidisciplinary management of gastrointestinal cancer. Biliary tract cancers: from pathogenesis to endoscopic treatment.
    Demols A; Maréchal R; Devière J; Van Laethem JL
    Best Pract Res Clin Gastroenterol; 2007; 21(6):1015-29. PubMed ID: 18070701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis and management of cholangiocarcinomas: a comprehensive review.
    Yalcin S
    Hepatogastroenterology; 2004; 51(55):43-50. PubMed ID: 15011829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diagnostics and treatment of cholangiocarcinoma].
    Mantel HT; Verdonk RC; van Dullemen HM; Gietema JA; Slooff MJ; Porte RJ
    Ned Tijdschr Geneeskd; 2008 May; 152(18):1037-41. PubMed ID: 18547024
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bile duct malignancies.
    Tucek S; Tomasek J; Halámkova J; Kiss I; Andrasina T; Hemmelová B; Adámková-Krákorová D; Vyzula R
    Klin Onkol; 2010; 23(4):231-41. PubMed ID: 20806821
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population.
    Chantajitr S; Wilasrusmee C; Lertsitichai P; Phromsopha N
    J Hepatobiliary Pancreat Surg; 2006; 13(6):537-42. PubMed ID: 17139428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholangiocarcinoma: A position paper by the Italian Society of Gastroenterology (SIGE), the Italian Association of Hospital Gastroenterology (AIGO), the Italian Association of Medical Oncology (AIOM) and the Italian Association of Oncological Radiotherapy (AIRO).
    Alvaro D; Cannizzaro R; Labianca R; Valvo F; Farinati F; ; ; ;
    Dig Liver Dis; 2010 Dec; 42(12):831-8. PubMed ID: 20702152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on the Diagnosis and Treatment of Cholangiocarcinoma.
    Doherty B; Nambudiri VE; Palmer WC
    Curr Gastroenterol Rep; 2017 Jan; 19(1):2. PubMed ID: 28110453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for cholangiocarcinoma.
    Ben-Menachem T
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):615-7. PubMed ID: 17625428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma.
    Esnaola NF; Meyer JE; Karachristos A; Maranki JL; Camp ER; Denlinger CS
    Cancer; 2016 May; 122(9):1349-69. PubMed ID: 26799932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endoscopic sphincterotomy and long-term risk of cholangiocarcinoma: a population-based follow-up study.
    Mortensen FV; Jepsen P; Tarone RE; Funch-Jensen P; Jensen LS; Sørensen HT
    J Natl Cancer Inst; 2008 May; 100(10):745-50. PubMed ID: 18477806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholangiocarcinoma: natural history, treatment, and strategies for surveillance in high-risk patients.
    Yachimski P; Pratt DS
    J Clin Gastroenterol; 2008 Feb; 42(2):178-90. PubMed ID: 18209589
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical presentation, risk factors and staging systems of cholangiocarcinoma.
    Plentz RR; Malek NP
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):245-52. PubMed ID: 25966425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review article: the modern diagnosis and therapy of cholangiocarcinoma.
    Malhi H; Gores GJ
    Aliment Pharmacol Ther; 2006 May; 23(9):1287-96. PubMed ID: 16629933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma.
    Bridgewater J; Galle PR; Khan SA; Llovet JM; Park JW; Patel T; Pawlik TM; Gores GJ
    J Hepatol; 2014 Jun; 60(6):1268-89. PubMed ID: 24681130
    [No Abstract]   [Full Text] [Related]  

  • 38. Cholangiocarcinoma.
    Khan AS; Dageforde LA
    Surg Clin North Am; 2019 Apr; 99(2):315-335. PubMed ID: 30846037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiological aspects of biliary tree tumors in a region of northern Italy: emerging trends and sex-based differences.
    Floreani A; Lisiero M; Baldovin T; Baldo V
    Eur J Gastroenterol Hepatol; 2013 Nov; 25(11):1347-51. PubMed ID: 24081106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The retrospective analysis of HBV and HCV infection in cholangiocarcinoma].
    Zou SQ; Liu XF; Guo RX; Li CL; Zhou XS; Zhu XG; Huang ZQ
    Zhonghua Wai Ke Za Zhi; 2003 Jun; 41(6):417-9. PubMed ID: 12895347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.